The CEO of Arcus Biosciences talks TIGIT, adenosine, and HIF-2α at #ASCO24
Terry Rosen describes data presented at ASCO for TIGIT in upper GI cancers, adenosine in late state colorectal cancer, and non-ASCO data that will be coming up in the second half of the year for HIF-2α in renal.
Comments